InsidersTradesSigma
Follow the Corline Biomedical AB stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Corline Biomedical AB has recorded 1 public disclosures. Market capitalisation: €462.6m. The latest transaction was filed on 17 February 2026 (Purchase). Among the most active insiders: Henrik Nittmar. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Corline Biomedical AB is a company focused on developing biopharmaceutical products. It specializes in innovative solutions for the treatment of serious diseases.